Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review.
Citizenship
hepatitis C
identity
recovery
social network
stigma
substance use
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
22
02
2022
accepted:
10
08
2022
pubmed:
23
8
2022
medline:
7
2
2023
entrez:
22
8
2022
Statut:
ppublish
Résumé
People who inject drugs are at high risk of contracting hepatitis C (HCV). The introduction of direct acting antiviral (DAA) drugs to treat HCV has the potential to transform care; however, uptake of DAAs has been slower than anticipated. The strong link between HCV and injecting drug use frames HCV as a shameful, stigmatising disease, reinforcing an 'addict' identity. Linking HCV care to a recovery journey, 'clean' identity and social redemption may provide compelling encouragement for people to engage with treatment and re-evaluate risk and behaviours, reducing the incidence of HCV re-infection. The aim of this review was to identify actions, interventions and treatments that provide an opportunity for a change in identity and support a recovery journey and the implications for HCV care. Databases (MEDLINE, EMBASE, PsycINFO, ProQuest Public Health, ProQuest Sociological Abstracts, CINAHL and Web of Science) were searched following our published strategy and a grey literature search conducted. A narrative synthesis was undertaken to collate themes and identify common threads and provide an explanation of the findings. Thirty-two studies fulfilled the inclusion criteria. The narrative synthesis of the studies identified five over-arching analytical themes: social factors in substance use and recovery, therapeutic communities, community treatment, online communities, and finally women and youth subsets. The change from an 'addict' identity to a 'recovery' identity is described as a key aspect of a recovery journey, and this process can be supported through social support and turning point opportunities. Recovery from addiction is a socially mediated process. Actions, interventions and treatments that support a recovery journey provide social connections, a recovery identity and citizenship (reclaiming a place in society). There is a gap in current literature describing how pathways of care with direct acting antivirals can be designed to promote recovery, as part of hepatitis C care.
Sections du résumé
BACKGROUND AND AIM
People who inject drugs are at high risk of contracting hepatitis C (HCV). The introduction of direct acting antiviral (DAA) drugs to treat HCV has the potential to transform care; however, uptake of DAAs has been slower than anticipated. The strong link between HCV and injecting drug use frames HCV as a shameful, stigmatising disease, reinforcing an 'addict' identity. Linking HCV care to a recovery journey, 'clean' identity and social redemption may provide compelling encouragement for people to engage with treatment and re-evaluate risk and behaviours, reducing the incidence of HCV re-infection. The aim of this review was to identify actions, interventions and treatments that provide an opportunity for a change in identity and support a recovery journey and the implications for HCV care.
METHODS
Databases (MEDLINE, EMBASE, PsycINFO, ProQuest Public Health, ProQuest Sociological Abstracts, CINAHL and Web of Science) were searched following our published strategy and a grey literature search conducted. A narrative synthesis was undertaken to collate themes and identify common threads and provide an explanation of the findings.
RESULTS
Thirty-two studies fulfilled the inclusion criteria. The narrative synthesis of the studies identified five over-arching analytical themes: social factors in substance use and recovery, therapeutic communities, community treatment, online communities, and finally women and youth subsets. The change from an 'addict' identity to a 'recovery' identity is described as a key aspect of a recovery journey, and this process can be supported through social support and turning point opportunities.
CONCLUSIONS
Recovery from addiction is a socially mediated process. Actions, interventions and treatments that support a recovery journey provide social connections, a recovery identity and citizenship (reclaiming a place in society). There is a gap in current literature describing how pathways of care with direct acting antivirals can be designed to promote recovery, as part of hepatitis C care.
Identifiants
pubmed: 35993427
doi: 10.1111/add.16031
pmc: PMC10087584
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
425-437Informations de copyright
© 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Int J Drug Policy. 2021 Aug;94:103200
pubmed: 33765517
J Community Psychol. 2019 Jul;47(6):1399-1418
pubmed: 31038224
Health (London). 2015 Sep;19(5):473-89
pubmed: 25377666
Br J Soc Psychol. 2015 Jun;54(2):236-54
pubmed: 25209252
Psychol Addict Behav. 2013 Dec;27(4):1132-40
pubmed: 23586453
Addict Behav. 2015 May;44:35-42
pubmed: 25468675
Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109147
pubmed: 34749199
Psychol Addict Behav. 2018 Sep;32(6):595-604
pubmed: 30070538
Psychiatry Res. 2017 Jan;247:265-275
pubmed: 27936438
Stat Med. 2013 Feb 20;32(4):556-77
pubmed: 22711416
J Viral Hepat. 2019 May;26(5):519-528
pubmed: 30422370
Can J Gastroenterol Hepatol. 2017;2017:3268650
pubmed: 28529936
Int J Drug Policy. 2019 Oct;72:77-83
pubmed: 31221475
J Subst Abuse Treat. 2007 Oct;33(3):221-8
pubmed: 17889294
Fam Process. 2020 Mar;59(1):94-110
pubmed: 30556171
Sociol Health Illn. 2013 Sep;35(7):1023-44
pubmed: 23701040
Clin Infect Dis. 2013 Aug;57 Suppl 2:S51-5
pubmed: 23884066
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Addiction. 2014 Mar;109(3):452-9
pubmed: 24678545
J Health Psychol. 2022 Jan;27(1):69-80
pubmed: 32693631
Soc Sci Med. 2000 May;50(10):1501-10
pubmed: 10741584
Front Psychol. 2015 Nov 30;6:1795
pubmed: 26648882
Int J Drug Policy. 2019 Oct;72:99-105
pubmed: 31303262
Addiction. 2023 Mar;118(3):425-437
pubmed: 35993427
Qual Health Res. 2009 Sep;19(9):1321-34
pubmed: 19690211
Drug Alcohol Depend. 2011 Apr 1;114(2-3):119-26
pubmed: 21035276
Liver Int. 2020 Mar;40(3):522-529
pubmed: 31815353
Addiction. 2014 Dec;109(12):2060-1
pubmed: 25384936
Subst Abus. 2015;36(3):380-8
pubmed: 24960629
Int J Drug Policy. 2018 Oct;60:24-32
pubmed: 30092546
Int J Drug Policy. 2016 Dec;38:21-28
pubmed: 27842250
Drug Alcohol Rev. 2012 May;31(3):334-41
pubmed: 21615809
Can J Gastroenterol. 2013 Apr;27(4):217-23
pubmed: 23616960
BMJ Open. 2022 Feb 07;12(2):e049713
pubmed: 35131816
Harm Reduct J. 2018 Aug 15;15(1):42
pubmed: 30111327
J Hepatol. 2017 Oct;67(4):665-666
pubmed: 28760329
J Subst Abuse Treat. 2007 Oct;33(3):229-41
pubmed: 17889295
Qual Health Res. 2015 Mar;25(3):371-85
pubmed: 25231945
Health (London). 2010 May;14(3):272-91
pubmed: 20427634
Addiction. 2008 Oct;103(10):1593-603
pubmed: 18821870
Subst Abuse Treat Prev Policy. 2020 Jul 31;15(1):53
pubmed: 32736568
Psychol Psychother. 2021 Jun;94(2):307-321
pubmed: 32725864
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000858
pubmed: 30775014
Addict Behav. 2019 Jun;93:204-211
pubmed: 30738929
Subst Abuse Treat Prev Policy. 2015 Nov 11;10:45
pubmed: 26560076
Int J Drug Policy. 2014 Mar;25(2):204-11
pubmed: 24332457
Soc Sci Med. 2019 Sep;237:112459
pubmed: 31404883
Int J Drug Policy. 2015 Feb;26 Suppl 1:S22-6
pubmed: 25245939
J Affect Disord. 2002 Dec;72(3):237-41
pubmed: 12450640
Drugs Alcohol Today. 2016;16(1):95-105
pubmed: 27668008
Soc Sci Med. 2017 Nov;193:110-117
pubmed: 29032310